Watch ENGN. Know when insiders buy.
One email the day a filing lands. Free.
ENGN
enGene Therapeutics Inc.
1.59
+0.00 +0.32%
USD · close Oct 27
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
78
PASS · insiders 56, shorts 100
Insiders, 90 days
+$10K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $106.2MP/E 0.5DIV YIELD —FCF YIELD -97.91%REV TTM —NET INCOME −$130.4MNET CASH —52W 1.44 – 12.17SEC XBRL · TTM TO Invalid Date
How ENGN rewrote its risk factors
We have one 10-K for ENGN (FY2025, 51,607 words of risk factors). The comparison appears when the next annual report lands. Read it on EDGAR ↗